In addition, lidocaine was shown to inhibit the growth of luminal, TN, and human epidermal growth factor receptor 2 (HER-2)–positive breast cancer cell lines in vitro, the migration of breast tumor epithelial cells relative to normal breast epithelial cells, and the anchorage-independent growth of TN breast cancer cells (73). This evidence concerns the gene ERBB2 and breast carcinoma.